Press Releases

Month Year

Month Year

Investor Alerts

Oct 10, 2018

Trevi Therapeutics Appoints Anne M. VanLent to Board of Directors
Sep 27, 2018

Trevi Therapeutics Initiates Pivotal Clinical Trial of Nalbuphine ER for the Treatment of Pruritus in Prurigo Nodularis
Jul 19, 2018

Trevi Therapeutics Appoints Yann Mazabraud as Chief Commercial Officer and Head of International
May 17, 2018

Trevi Therapeutics to Present at UBS Global Healthcare Conference
May 15, 2018

Trevi Therapeutics Appoints Christopher J. Seiter as Chief Financial Officer

Show per page

Media Contact

Katie McManus
(203) 903-9627
k.mcmanus@trevitherapeutics.com

Trevi Therapeutics
195 Church Street, 14th Floor
New Haven, CT 06510
map